FlexiOss
Commercial- Indications
- Bone defects, Dental bone defects, Osteomyelitis, Hip dysplasia, Bone tumors
Company intelligence / Profile preview
Medical Inventi has developed and commercialized FlexiOss®, a hydroxyapatite-based flexible bone substitute biomaterial used in orthopedics, dentistry, and veterinary medicine. The product is CE-certified and available in multiple international markets. Clinical studies have confirmed its effectiveness in stimulating natural bone reconstruction while minimizing patient pain and recovery time. Ongoing R&D includes further clinical trials for dental applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Inventi.